Cannon Global Investment Management, LLC Eq Rx, Inc. Transaction History

Cannon Global Investment Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	BUY	$1.66 - $2.31 $207,500 - $288,750	125,000 New	125,000 $278 Million
Q2 2022 Aug 04, 2022	SELL	$3.2 - $5.69 $556,160 - $988,922	-173,800 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$2.8 - $7.39 $416,640 - $1.1 Million	148,800 Added 595.2%	173,800 $718,000
Q4 2021 Feb 04, 2022	BUY	$5.92 - $9.98 $148,000 - $249,500	25,000 New	25,000 $171,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Cannon Global Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cannon Global Investment Management, LLC with notifications on news.